Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.04 USD | -3.74% | -1.00% | +63.80% |
May. 20 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
May. 14 | Enliven Therapeutics Q1 Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.80% | 1.13B | |
+9.92% | 118B | |
+9.90% | 106B | |
-11.23% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.66% | 15.97B | |
+6.74% | 14.03B | |
+15.85% | 11.67B |
- Stock Market
- Equities
- ELVN Stock
- News Enliven Therapeutics, Inc.
- Enliven Therapeutics Q3 Loss Narrows